Creative Biolabs-Immuno-oncology

Oncology Assay Tools

Driving Precision Oncology Forward

Creative Biolabs launches a comprehensive array of Assays designed to cater to diverse research needs within the field of oncology. Please feel free to choose the products you need.

Assays A Brief Introduction
RNA Modification-Mediated Oncology Metabolomics Assays Creative Biolabs provides RNA-based oncology metabolomics analysis research tools, aiming to offering new insights for the development of molecular targeted novel cancer immunotherapies. By integrating various RNA modification techniques into multiple metabolomics analyses, we have developed a robust analytical tool that can be utilized to uncover potential interactions among all classes of molecules in tumors.
In Vitro Cell Binding Assay Creative Biolabs has developed a diverse array of in vitro cell binding assay kits, leveraging the CHOK1, HEK293, and Jurkat cell lines. Encompassing a wide spectrum of popular targets from human, Cyno, mouse, and Woodchuck, these assays predominantly utilize cell-based ELISA and cell-based FACS methodologies. Tailored as bespoke solutions, this product line is adept at accommodating the unique demands of our clientele.
Angiogenesis Monitoring Assays Angiogenesis monitoring assays can be used for the assessment and understanding of angiogenic processes within tumor development and progression. These assays facilitate the observation and quantification of angiogenesis, and the formation of new blood vessels from existing vasculature, which is a hallmark of cancer growth and metastasis.
Cell Migration and Invasion Assays Cell migration and invasion assays play a pivotal role in oncology research by providing valuable insights into the metastatic processes of cancer cells. These assays enable the study of cellular behaviors such as migration and invasion, which are fundamental to cancer progression and dissemination.
Cell Viability Assays Cell viability assays are indispensable tools in oncology research, providing critical insights into the response of cancer cells to various treatments and environmental conditions. These assays assess the viability of cancer cells by measuring their ability to maintain metabolic activity, integrity of cellular membranes, and overall cellular health.
Cell Proliferation Assays Cell proliferation assays play a crucial role in oncology research by enabling the quantitative assessment of cancer cell growth and proliferation. These assays provide valuable information about the rate of cell division, which is a key determinant of tumor growth, progression, and response to therapy.
Cellular Senescence in Cancer Assays This assay provides insights into the phenomenon of cellular senescence and its implications in cancer development and treatment. Cellular senescence, a state of irreversible growth arrest, can have both tumor-suppressive and tumor-promoting effects depending on context.
Detection of Apoptosis Assays Detection of apoptosis assays plays a critical role in Oncology research by facilitating the assessment of apoptotic cell death, a fundamental process involved in tumor development, progression, and response to therapy.
Energy Metabolism Detection Assays Energy metabolism detection assays play a significant role in Oncology research by enabling the study of alterations in cellular metabolism associated with cancer development, progression, and therapeutic response. Dysregulated energy metabolism is a hallmark of cancer, influencing tumor growth, metastasis, and treatment resistance.
Gene and Protein Expression Assays Gene and protein expression assays provide insights into the dysregulation of gene and protein expression patterns associated with cancer development, progression, and response to therapy.
Genome Alteration Assays Genome alteration assays provide valuable insights into the molecular landscape of cancer genomes and facilitate the identification of potential therapeutic targets and biomarkers for cancer diagnosis and treatment.
High-throughput Screening Assay High-throughput screening assays enable the rapid and systematic screening of large compound libraries or genetic perturbations to identify novel therapeutic agents, drug targets, and biomarkers for cancer diagnosis and treatment. These assays provide a scalable and efficient approach to drug discovery and functional genomics, accelerating the translation of research findings into clinical applications.
High Content Screening Assay High content screening assays enable the comprehensive analysis of complex cellular phenotypes and molecular processes associated with cancer development, progression, and therapeutic response. These assays integrate automated imaging, image analysis, and data mining techniques to quantify multiple cellular parameters simultaneously, providing valuable insights into cancer biology and accelerating drug discovery and development efforts.
Reporter Gene Assay Reporter gene assays enable the quantitative analysis of gene expression, transcriptional regulation, and signal transduction pathways involved in cancer development, progression, and therapeutic response. These assays utilize reporter genes, such as luciferase or green fluorescent protein (GFP), to monitor the activity of specific promoters or regulatory elements in response to various stimuli or treatments, providing valuable insights into molecular mechanisms underlying oncogenesis and drug action.
Tumorigenesis Assay Tumorigenesis assays enable the study of cancer initiation, progression, and metastasis in experimental models, providing insights into the molecular mechanisms underlying oncogenesis and identifying potential therapeutic targets for cancer treatment. These assays utilize in vitro and in vivo models to recapitulate key aspects of tumorigenesis, including cell transformation, tumor growth, angiogenesis, invasion, and metastasis, facilitating the development and validation of novel anticancer therapies.
Metastasis Assay Metastasis assays enable the study of the metastatic process, which is a critical determinant of cancer progression and survival. They serve several key functions, including modeling metastatic cascade, evaluation of metastatic potential, screening for metastasis inhibitors, and investigation of microenvironmental influences.
Oncology Efficacy Assays Efficacy assays assess various parameters related to tumor growth, regression, and survival, providing valuable insights into treatment response and guiding the development of novel therapeutic strategies for cancer management.
Oxidative Stress Assays Oxidative stress assays facilitate the assessment of oxidative stress levels and their impact on cancer development, progression, and response to therapy.
Tumor Cell Analysis Assay This assay empowers researchers to analyze the expression levels of specific molecular targets on tumor cells. By assessing the expression profiles of proteins, receptors, or biomarkers implicated in oncogenesis, metastasis, or treatment response, researchers gain insights into potential therapeutic targets and patient stratification for personalized treatment strategies.

If our existing products do not meet your needs, please contact us to determine your requirements and see if we can assist you.

For Research Use Only | Not For Clinical Use

Filters

Claudin18.2 (Mouse) Cell Binding Assay, HEK293/Claudin18.2-based(CAT#: ITS-1122-LX53)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/Claudin18.2 (Mouse)
Assay Type: Cell Binding Assay
Claudin18.1 (Human) Cell Binding Assay, HEK293/Claudin18.1-based(CAT#: ITS-1122-LX54)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/Claudin18.1 (Human)
Assay Type: Cell Binding Assay
Adenosine A2A Receptor (Human) Cell Binding Assay, HEK293/Adenosine A2A Receptor-based(CAT#: ITS-1122-LX57)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/Adenosine A2A Receptor (Human)
Assay Type: Cell Binding Assay
CD137 (Human) Cell Binding Assay, HEK293/CD137-based(CAT#: ITS-1122-LX58)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CD137 (Human)
Assay Type: Cell Binding Assay
CD155 (Human) Cell Binding Assay, HEK293/CD155-based(CAT#: ITS-1122-LX59)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CD155 (Human)
Assay Type: Cell Binding Assay
CD47 (Human) Cell Binding Assay, HEK293/CD47-based(CAT#: ITS-1122-LX60)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CD47 (Human)
Assay Type: Cell Binding Assay
CTLA-4 (Human) Cell Binding Assay, HEK293/CTLA-4-based(CAT#: ITS-1122-LX61)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CTLA-4 (Human)
Assay Type: Cell Binding Assay
GITR (Human) Cell Binding Assay, HEK293/GITR-based(CAT#: ITS-1122-LX62)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/GITR (Human)
Assay Type: Cell Binding Assay
TLR8 (Human) Binding Molecules Screening Assay, HEK293/TLR8-based(CAT#: ITS-1122-LX184)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/TLR8 (Human)
Assay Type: Cell Binding Assay
B16F10 In Vitro Confocal Microscopy-based Apoptosis Assay(CAT#: ITS-1022-YF35)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
IDO1 (Human) Cell Binding Assay, HEK293/IDO1-based(CAT#: ITS-1122-LX63)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/IDO1 (Human)
Assay Type: Cell Binding Assay
PD-1 (Human) Binding Molecules Screening Assay, Jurkat/PD-1-based(CAT#: ITS-1122-LX186)
Target Cell Organism: Human
Target Cell Alternative Name: Jurkat
Target Cell Name: Jurkat/PD-1 (Human)
Assay Type: Cell Binding Assay
Claudin18.2 (Mouse) Binding Molecules Screening Assay, HEK293/Claudin18.2-based(CAT#: ITS-1122-LX146)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/Claudin18.2 (Mouse)
Assay Type: Cell Binding Assay
B16F10 In Vitro Reporter Gene (Placental Alkaline Phosphatase) Assay(CAT#: ITS-1022-YF101)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
K562 In Vitro Glutathione Assay (Oxidative Stress)(CAT#: ITS-1022-YF175)
Target Cell Organism: Human
Target Cell Alternative Name: K-562
Target Cell Name: K562
Assay Type: Oxidative Stress Assays
GL261 In Vitro Comet-based DNA Damage Assay (Apoptosis )(CAT#: ITS-1022-YF252)
Target Cell Organism: Mouse
Target Cell Alternative Name: Glioma 261
Target Cell Name: GL261
Assay Type: Detection of Apoptosis Assays
U87 MG In Vitro SRB Assay (Cell Viability)(CAT#: ITS-1022-YF323)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
B16F10 In Vitro Cell Membrane Integrity-based Apoptosis Assay (FCM)(CAT#: ITS-1022-YF36)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
B16F10 In Vitro Caspase Activation-based Apoptosis Assay (FCM)(CAT#: ITS-1022-YF37)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
In Vitro Doxycycline Stimulation Assay, HEK293/T-Rex-based(CAT#: ITS-1122-LX188)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293/T-Rex (Human)
Target Cell Name: HEK293
Assay Type: Doxycycline Stimulation Assay
B16F10 In Vitro Mitochondrial Membrane Potential-based Apoptosis Assay (FCM)(CAT#: ITS-1022-YF38)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
Claudin18.1 (Human) Binding Molecules Screening Assay, HEK293/Claudin18.1-based(CAT#: ITS-1122-LX147)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/Claudin18.1 (Human)
Assay Type: Cell Binding Assay
B16F10 In Vitro Annexin V-based Apoptosis Assay (FCM)(CAT#: ITS-1022-YF39)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
Adenosine A2A Receptor (Human) Binding Molecules Screening Assay, HEK293/Adenosine A2A Receptor-based(CAT#: ITS-1122-LX150)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/Adenosine A2A Receptor (Human)
Assay Type: Cell Binding Assay
CD137 (Human) Binding Molecules Screening Assay, HEK293/CD137-based(CAT#: ITS-1122-LX151)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CD137 (Human)
Assay Type: Cell Binding Assay
CD155 (Human) Binding Molecules Screening Assay, HEK293/CD155-based(CAT#: ITS-1122-LX152)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CD155 (Human)
Assay Type: Cell Binding Assay
CD47 (Human) Binding Molecules Screening Assay, HEK293/CD47-based(CAT#: ITS-1122-LX153)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CD47 (Human)
Assay Type: Cell Binding Assay
B16F10 In Vitro Agarose Gel Electrophoresis-based DNA Fragmentation Assay (Apoptosis )(CAT#: ITS-1022-YF40)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
CTLA-4 (Human) Binding Molecules Screening Assay, HEK293/CTLA-4-based(CAT#: ITS-1122-LX154)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/CTLA-4 (Human)
Assay Type: Cell Binding Assay
GITR (Human) Binding Molecules Screening Assay, HEK293/GITR-based(CAT#: ITS-1122-LX155)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/GITR (Human)
Assay Type: Cell Binding Assay
IDO1 (Human) Binding Molecules Screening Assay, HEK293/IDO1-based(CAT#: ITS-1122-LX156)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/IDO1 (Human)
Assay Type: Cell Binding Assay
B16F10 In Vitro TUNEL-based DNA Fragmentation Assay (Apoptosis )(CAT#: ITS-1022-YF41)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
IDO2 (Human) Binding Molecules Screening Assay, HEK293/IDO2-based(CAT#: ITS-1122-LX157)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/IDO2 (Human)
Assay Type: Cell Binding Assay
HVEM (Human) Binding Molecules Screening Assay, HEK293/HVEM-based(CAT#: ITS-1122-LX158)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/HVEM (Human)
Assay Type: Cell Binding Assay
OX40 (Human) Binding Molecules Screening Assay, HEK293/OX40-based(CAT#: ITS-1122-LX159)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/OX40 (Human)
Assay Type: Cell Binding Assay
PD-1 (Human) Binding Molecules Screening Assay, HEK293/PD-1-based(CAT#: ITS-1122-LX160)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/PD-1 (Human)
Assay Type: Cell Binding Assay
SIRP-α (Human) Binding Molecules Screening Assay, HEK293/SIRP-α-based(CAT#: ITS-1122-LX161)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/SIRP-α (Human)
Assay Type: Cell Binding Assay
TDO (Human) Binding Molecules Screening Assay, HEK293/TDO-based(CAT#: ITS-1122-LX162)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/TDO (Human)
Assay Type: Cell Binding Assay
TIGIT (Human) Binding Molecules Screening Assay, HEK293/TIGIT-based(CAT#: ITS-1122-LX163)
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/TIGIT (Human)
Assay Type: Cell Binding Assay
B16F10 In Vitro Anti-Tumor Efficacy Assay(CAT#: ITS-1022-YF102)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Oncology Efficacy Assays
U87 MG In Vitro Comparative Genomic Hybridization (CGH) Assay(CAT#: ITS-1022-YF397)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Genome Alteration Assays
U87 MG In Vitro Restriction Landmark Genome Scanning (RLGS) Assay(CAT#: ITS-1022-YF398)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Genome Alteration Assays
U87 MG In Vitro Representational Difference Analysis (RDA) Assay(CAT#: ITS-1022-YF399)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Genome Alteration Assays
U87 MG In Vitro Genome Sequencing Assay(CAT#: ITS-1022-YF400)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Genome Alteration Assays
B16F10 In Vitro Comet-based DNA Damage Assay (Apoptosis )(CAT#: ITS-1022-YF42)
Target Cell Organism: Mouse
Target Cell Alternative Name: B16-F10
Target Cell Name: B16F10
Assay Type: Detection of Apoptosis Assays
U87 MG In Vitro RNA Expression Analysis Assay (Northern Blooting)(CAT#: ITS-1022-YF401)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Gene and Protein Expression Assays
U87 MG In Vitro RNA Expression Analysis Assay (DNA Microarray)(CAT#: ITS-1022-YF402)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Gene and Protein Expression Assays
U87 MG In Vitro RNA Expression Analysis Assay (Real-time PCR)(CAT#: ITS-1022-YF403)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Gene and Protein Expression Assays
U87 MG In Vitro RNA Expression Analysis Assay (SAGE)(CAT#: ITS-1022-YF404)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Gene and Protein Expression Assays
U87 MG In Vitro RNA Expression Analysis Assay (Cap Analysis)(CAT#: ITS-1022-YF405)
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Gene and Protein Expression Assays
Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.